| |
| Issue |
Title |
| |
| No 1 (2025) |
Certain aspects of the methodology of conducting clinical trials of drugs for the treatment of Alzheimer’s disease |
Abstract
PDF (Rus)
|
|
A. P. Solovyova, I. M. Surmilo |
| |
| No 1 (2025) |
Calibration of the influence of external factors — country, city (infrastructure), and income on patient recruitment in clinical trials |
Abstract
PDF (Rus)
|
|
S. S. Milovanov, N. V. Polunina, V. V. Popov, N. V. Teplova |
| |
| No 2 (2024) |
Pharmacotherapy with alpha-1 adrenergic blockers and lipid spectrum correction in patients with urinary disorders |
Abstract
PDF (Rus)
|
|
V. V. Danilov, E. V. Eliseeva, V. V. Danilov, I. Yu. Volnykh, A. V. Tyrtyshnikova, M. M. Piskun, V. V. Danilov |
| |
| No 2 (2024) |
Medical and biological research data |
Abstract
PDF (Rus)
|
|
A. F. Martsinkevich |
| |
| No 1 (2024) |
Ideal recruitment rate in clinical trials in phases II–III |
Abstract
PDF (Rus)
|
|
S. S. Milovanov |
| |
| No 4 (2023) |
Changing the first screening parameters for patients and their derivatives in Phase II–III clinical studies |
Abstract
PDF (Rus)
|
|
S. S. Milovanov |
| |
| No 2 (2023) |
Risks of clinical trial protocol amendments according to duration of the trial |
Abstract
PDF (Rus)
|
|
A. A. Eleskina, N. V. Pyatigorskaya, O. V. Filippova |
| |
| No 4 (2022) |
Specifics of motivation of volunteers participating in in a clinical trial of the COVID-19 vaccine |
Abstract
PDF (Rus)
|
|
Y. D. Belousova, V. V. Rafalsky, E. D. Kislova |
| |
| No 4 (2022) |
Factors, influencing to the recruitment of international multicenter clinical trials of II–III phases |
Abstract
PDF (Rus)
|
|
S. S. Milovanov |
| |
| No 3 (2020) |
Pragmatic clinical trials |
Abstract
PDF (Rus)
|
|
O. R. Shevchenko, A. S. Kolbin |
| |
| No 1 (2020) |
Current aspects of risk management in clinical trials |
Abstract
PDF (0,8 МБ) (Rus)
|
|
E. A. Polozova |
| |
| No 1 (2019) |
Evaluation of immunogenicity, efficacy and safety of GP40041 compared to Humulin® NPH in patients with type 2 diabetes mellitus |
Abstract
PDF (1,4 Мб) (Rus)
|
|
A. G. Zalevskaya, A. A. Mosikian, O. V. Afonkina, R. V. Drai |
| |
| No 2 (2018) |
The role of reference intervals of laboratory tests in early phase clinical research in healthy volunteers |
Abstract
PDF (Rus)
|
|
A. V. Vozzhaev, S. B. Fitilev, I. I. Shkrebniova, D. A. Kliuev, A. A. Vdovina, L. A. Miasnikova |
| |
| No 2 (2018) |
The problem of over-volunteering in early phase clinical trials |
Abstract
PDF (Rus)
|
|
S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebniova, D. A. Kliuev |
| |
| No 4 (2003) |
Исследование миллиона женщин |
Abstract
PDF (Rus)
|
|
|
| |
| No 4 (2003) |
Анализ данных клинического исследования |
Abstract
PDF (Rus)
|
|
|
| |
| No 1 (2004) |
Заключительный отчет клинического исследования и практика публикаций |
Abstract
PDF (Rus)
|
|
|
| |
| No 2 (2005) |
Клинические испытания с участием детей |
Abstract
PDF (Rus)
|
|
|
| |
| No 3 (2014) |
The methodology of calculation of sample size in “non-inferiority” comparative controlled clinical trials: a comparison of two proportions in parallel group |
Abstract
PDF (Rus)
|
|
A. A. Lyashenko, M. S. Svishcheva |
| |
| No 3 (2008) |
Оптимизация фармакотерапии хронической сердечной недостаточности с помощью отечественного β-адреноблокатора проксадола |
Abstract
PDF (Rus)
|
|
, |
| |
| No 3 (2008) |
Влияние фозиноприла, амлодипина и метопролола на обратное развитие процессов ремоделирования органов-мишеней у больных артериальной гипертонией |
Abstract
PDF (Rus)
|
|
, , |
| |
| No 2 (2008) |
Подготовка специалистов в области проведения клинических исследований лекарственных средств в системе послевузовского профессионального образования врачей |
Abstract
PDF (Rus)
|
|
, |
| |
| No 2 (2008) |
Клинические исследования в педиатрической практике |
Abstract
PDF (Rus)
|
|
, |
| |
| No 2 (2008) |
Исследования с бисопрололом при хронической сердечной недостаточности: CIBIS, CIBIS II и CIBIS III |
Abstract
PDF (Rus)
|
|
|
| |
| 1 - 24 of 65 Items |
1 2 3 > >>
|
